Cargando…

Ontogeny‐based immunogens for the induction of V2‐directed HIV broadly neutralizing antibodies

The development of a preventative HIV vaccine able to elicit broadly neutralizing antibodies (bNAbs) remains a major challenge. Antibodies that recognize the V2 region at the apex of the HIV envelope trimer are among the most common bNAb specificities during chronic infection and many exhibit remark...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moore, Penny L., Gorman, Jason, Doria‐Rose, Nicole A., Morris, Lynn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Invited Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5300058/ https://www.ncbi.nlm.nih.gov/pubmed/28133797 http://dx.doi.org/10.1111/imr.12501

Ejemplares similares

Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies
por: Bhiman, Jinal N., et al.
Publicado: (2015)

Identification and specificity of broadly neutralizing antibodies against HIV
por: McCoy, Laura E., et al.
Publicado: (2017)

Immunologic characteristics of HIV‐infected individuals who make broadly neutralizing antibodies
por: Borrow, Persephone, et al.
Publicado: (2017)

Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
por: Landais, Elise, et al.
Publicado: (2018)

Phenotypic deficits in the HIV-1 envelope are associated with the maturation of a V2-directed broadly neutralizing antibody lineage
por: Reh, Lucia, et al.
Publicado: (2018)

Combinations of Single Chain Variable Fragments From HIV Broadly Neutralizing Antibodies Demonstrate High Potency and Breadth
por: van Dorsten, Rebecca T., et al.
Publicado: (2021)

Ontogeny of Recognition Specificity and Functionality for the Broadly Neutralizing Anti-HIV Antibody 4E10
por: Finton, Kathryn A. K., et al.
Publicado: (2014)

Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques
por: Rosenberg, Yvonne, et al.
Publicado: (2015)

HIV Coinfection Provides Insights for the Design of Vaccine Cocktails to Elicit Broadly Neutralizing Antibodies
por: Sheward, Daniel J., et al.
Publicado: (2022)

Positive Selection at Key Residues in the HIV Envelope Distinguishes Broad and Strain-Specific Plasma Neutralizing Antibodies
por: Mabvakure, Batsirai M., et al.
Publicado: (2019)

HIV Broadly Neutralizing Antibodies Expressed as IgG3 Preserve Neutralization Potency and Show Improved Fc Effector Function
por: Richardson, Simone I., et al.
Publicado: (2021)

Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodies
por: Scheepers, Cathrine, et al.
Publicado: (2022)

Viral Vectors for the Induction of Broadly Neutralizing Antibodies against HIV
por: Wilmschen, Sarah, et al.
Publicado: (2019)

A1 The role of virus-antibody co-evolution in the development of a V3-glycan-directed HIV-1 broadly neutralizing antibody lineage
por: Kitchin, D, et al.
Publicado: (2019)

HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies
por: Richardson, Simone I., et al.
Publicado: (2018)

Extended antibody-framework-to-antigen distance observed exclusively with broad HIV-1-neutralizing antibodies recognizing glycan-dense surfaces
por: Lee, Myungjin, et al.
Publicado: (2021)

Sequencing HIV-neutralizing antibody exons and introns reveals detailed aspects of lineage maturation
por: Johnson, Erik L., et al.
Publicado: (2018)

Immune System Regulation in the Induction of Broadly Neutralizing HIV-1 Antibodies
por: Kelsoe, Garnett, et al.
Publicado: (2013)

Strategies for induction of HIV‐1 envelope‐reactive broadly neutralizing antibodies
por: Williams, Wilton B., et al.
Publicado: (2021)

IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody
por: Richardson, Simone I., et al.
Publicado: (2019)

Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope
por: Schoofs, Till, et al.
Publicado: (2019)

Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope
por: Anthony, Colin, et al.
Publicado: (2017)

Broadly Neutralizing Antibodies for HIV Eradication
por: Stephenson, Kathryn E., et al.
Publicado: (2016)

Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies
por: Briney, Bryan, et al.
Publicado: (2016)

Structures of HIV-1-Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design
por: Gorman, Jason, et al.
Publicado: (2015)

Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models
por: Lacerda, Miguel, et al.
Publicado: (2013)

Progress with induction of HIV broadly neutralizing antibodies in the Duke Consortia for HIV/AIDS Vaccine Development
por: Haynes, Barton F., et al.
Publicado: (2023)

Tackling influenza with broadly neutralizing antibodies
por: Corti, Davide, et al.
Publicado: (2017)

Limited Neutralizing Antibody Specificities Drive Neutralization Escape in Early HIV-1 Subtype C Infection
por: Moore, Penny L., et al.
Publicado: (2009)

Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses
por: Beltran-Pavez, Carolina, et al.
Publicado: (2022)

Isolation of broadly neutralizing HIV-1 antibodies from high-throughput single B cell culture
por: Longo, NS, et al.
Publicado: (2012)

Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
por: Huang, Jinghe, et al.
Publicado: (2012)

CD4+ T Cells Are Dispensable for Induction of Broad Heterologous HIV Neutralizing Antibodies in Rhesus Macaques
por: Sarkar, Sanghita, et al.
Publicado: (2021)

HIV vaccine development and broadly neutralizing antibodies
por: Greenspan, Neil S., et al.
Publicado: (2015)

The expanding array of HIV broadly neutralizing antibodies
por: McCoy, Laura E.
Publicado: (2018)

Broadly Neutralizing Antibodies for HIV-1 Prevention
por: Walsh, Stephen R., et al.
Publicado: (2021)

Broadly neutralizing monoclonal antibodies for HIV prevention
por: Miner, Maurine D., et al.
Publicado: (2021)

TRIM21: a cytosolic Fc receptor with broad antibody isotype specificity
por: Foss, Stian, et al.
Publicado: (2015)

Protocol to identify and monitor key mutations of broadly neutralizing antibody lineages following sequential immunization of Ig-humanized mice
por: Chen, Xuejun, et al.
Publicado: (2022)

Somatic hypermutation to counter a globally rare viral immunotype drove off-track antibodies in the CAP256-VRC26 HIV-1 V2-directed bNAb lineage
por: Sacks, David, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pnjq6fhenm8h8sjvr6bm2c3cp6